@prefix dc: .
@prefix this: .
@prefix sub: .
@prefix beldoc: .
@prefix rdfs: .
@prefix rdf: .
@prefix xsd: .
@prefix dce: .
@prefix pav: .
@prefix np: .
@prefix belv: .
@prefix prov: .
@prefix chebi: .
@prefix go: .
@prefix hasAnnotation: .
@prefix species: .
@prefix occursIn: .
@prefix mesh: .
@prefix pubmed: .
@prefix orcid: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
sub:_1 occursIn: mesh:D007728, mesh:D008099, mesh:D008930, species:9606;
hasAnnotation: sub:_2;
rdf:object go:0006635;
rdf:predicate belv:decreases;
rdf:subject chebi:2663;
a rdf:Statement .
sub:_2 dc:subject "TextLocation";
rdf:value "Review" .
sub:assertion rdfs:label "a(CHEBI:amiodarone) -| bp(GO:\"fatty acid beta-oxidation\")" .
}
sub:provenance {
beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds.";
dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved.";
dce:title "BEL Framework Small Corpus Document";
dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License";
pav:authoredBy sub:_4;
pav:version "1.6" .
sub:_3 prov:value """some drugs (e.g. amiodarone, amineptine, pirprofen) also inhibit microsomal triglyceride
transfer protein (MTP), an enzyme playing a major role in the formation
of very-low-density-lipoprotein (VLDL) particles [43]. Such drugs therefore inhibit
the two main pathways removing fat from the liver, namely FAO and hepatic VLDL
secretion.""";
prov:wasQuotedFrom pubmed:18705745 .
sub:_4 rdfs:comment "support@belframework.org";
rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:18705745;
prov:wasDerivedFrom beldoc:, sub:_3 .
}
sub:pubinfo {
this: dc:created "2014-07-03T14:29:31.090+02:00"^^xsd:dateTime;
pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}